Evidence map›Paper›PMID 42595826›Full record

ArticleEMBO molecular medicine2026

Disease-driven post-transcriptional alterations and alternative splicing in podocytes in focal segmental glomerulosclerosis.

Francescapaola Mattias, Olga Tsoy, Anna Iervolino, Stefan Simm, Elke Hammer, Alexander Gress, Florian Siegerist, Maximillian Schindler, Tim Lange, Sabine Ameling and 10 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Francescapaola MattiasDepartment of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0009-0006-2343-0283
Olga TsoyInstitute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
Anna IervolinoInstitute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
Stefan SimmCoburg University of Applied Sciences, Institute of Bioanalysis, Coburg, Germany.
Elke HammerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-1507-0402
Alexander GressDepartment of Drug Bioinformatics, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Florian SiegeristDepartment of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.
Maximillian SchindlerDepartment of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.
Tim LangeDepartment of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.
Sabine AmelingInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Tim KacprowskiInstitute of Data Science in Biomedicine, Technische Universität Braunschweig, Braunschweig, Germany.ORCID http://orcid.org/0000-0002-5393-2413
Markus ListData Science in Systems Biology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-0941-4168
Olga KalininaDepartment of Drug Bioinformatics, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Sören FranzenburgInstitute of Clinical Molecular Biology (IKMB), Kiel University, Kiel, Germany.
Giovambattista CapassoInstitute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
Karlhans EndlichDepartment of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0001-6052-6061
Jan BaumbachInstitute for Computational Systems Biology, University of Hamburg, Hamburg, Germany.
Uwe VölkerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.ORCID http://orcid.org/0000-0002-5689-3448
Nicole Endlich *Department of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany. nicole.endlich@uni-greifswald.de.ORCID http://orcid.org/0000-0001-6817-4099
Felix Kliewe *Department of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany. felix.kliewe@uni-greifswald.de.ORCID http://orcid.org/0000-0001-8717-5927

Funding

BMFTR 01ZX1908A + 01ZX2208ABMFTR 01ZX1908B + 01ZX2208BBMFTR 01ZX2208C + 01ZX1908C
6 · The paper itself

Abstract

Focal segmental glomerulosclerosis (FSGS) is a major cause of nephrotic syndrome and progression to end-stage renal disease, yet its molecular pathogenesis remains still incompletely defined. While transcriptional alterations in podocytes have been extensively characterized, the contribution of post-transcriptional regulatory mechanisms is poorly understood. Here, we combined a zebrafish podocyte-specific injury model with glomerulus-resolved transcriptomic profiling to dissect RNA regulatory alterations during FSGS progression. Integrated analyses of bulk RNA sequencing, small RNA profiling, and alternative splicing revealed pronounced, time-dependent remodeling of the glomerular transcriptome. We demonstrate that podocyte injury is associated with loss of key podocyte-specific proteins, activation of inflammatory pathways, remodeling of the extracellular matrix, and altered microRNA expression, such as miR-21 and miR-193. Moreover, we found that alternative splicing influences key podocyte gene expression, affecting genes critical for slit diaphragm integrity, actin cytoskeleton organization, and glomerular basement membrane stability. Isoform analyses identified FSGS-associated isoform switches in SRSF3 and EPB41L5. Importantly, these changes were also evident in glomeruli from FSGS patients, demonstrating that the zebrafish model recapitulates key molecular features of human disease and highlighting alternative splicing as a central regulatory mechanism in FSGS.

Indexed as

Alternative SplicingGlomerulosclerosis, Focal SegmentalPodocytesAnimalsDisease Models, AnimalGene Expression ProfilingHumansZebrafish

Identifiers

PMID42595826
PMCPMC13562739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.